PATHOLOGY RESEARCH AND PRACTICE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2023-05-31 ms9000001653410863 来自广东省

审稿速度:2.0
经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2023-09-06 我缺一套剑法来自辽宁省

偏重的研究方向：肿瘤;TCGA
经验分享：这个杂志接收生信文章吗

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2023-04-30 ms2000001978385449 来自内蒙古

请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2023-02-17 ms8000001946451800 来自陕西省

y

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2022-05-24 ms3000000226235188

审稿速度:3.0 | 投稿命中率:50.0
经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复

23 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2021-12-29 Mia

选刊时有什么原则吗？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2021-12-27 rayms

文章类型和选刊有关系吗？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2021-02-03 148b22fbm52(暂无昵称)

2020-10-28提交
2020-10-29 under review
2020-12-31 ready for decision
2021-01-11 maor review
2021-01-31 修回
2121-02-03 accept
总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。

101 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2020-11-29 12571bd1m76暂无昵称

审稿速度:3.0 | 投稿命中率:75.0
经验分享：动物组织形态免疫组化病理方面的容易投稿吗

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2140142, encodeId=f583214014239, content=审稿速度:2.0 经验分享：投了一篇综述，一个多月后告诉我一直无法确保审稿人愿意审阅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8ef8731723, createdName=ms9000001653410863, createdTime=Wed May 31 18:04:44 CST 2023, time=2023-05-31, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2156357, encodeId=5b3c215635e21, content=偏重的研究方向：肿瘤;TCGA 经验分享：这个杂志接收生信文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dea25569961, createdName=我缺一套剑法, createdTime=Wed Sep 06 12:21:35 CST 2023, time=2023-09-06, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2129382, encodeId=3f562129382ba, content=请问这个杂志是所有作者确认后才会推进后面的环节吗，提交了之后发送了让合著者确认的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cf48274489, createdName=ms2000001978385449, createdTime=Sun Apr 30 08:21:11 CST 2023, time=2023-04-30, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2115010, encodeId=bec7211501061, content=y, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10998256658, createdName=ms8000001946451800, createdTime=Fri Feb 17 00:47:15 CST 2023, time=2023-02-17, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1222138, encodeId=46ef1222138cf, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：修回去20天了还在with editor，，，发邮件得到的是爱斯维尔的敷衍答复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8c245556232, createdName=ms3000000226235188, createdTime=Tue May 24 18:57:57 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096497, encodeId=cc15109649e60, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096498, encodeId=3d7e1096498af, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922441, encodeId=535c92244110, content=2020-10-28提交 2020-10-29 under review 2020-12-31 ready for decision 2021-01-11 maor review 2021-01-31 修回 2121-02-03 accept 总体来说，一审周期比较长，期间催稿两次，第二天就给回复，编辑态度挺好。返修稿应该没送外审，一审的返回的意见逐条认真回复，接受应该问题不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ef595323187, createdName=148b22fbm52(暂无昵称), createdTime=Wed Feb 03 13:09:54 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903179, encodeId=97789031e9e0, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：动物组织形态免疫组化病理方面的容易投稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210808/fc552b42cd154706bb2cf25baecb02b2/554ea371740144a7a40f1dcfdbfbbc91.jpg, createdBy=e1942565806, createdName=12571bd1m76暂无昵称, createdTime=Sun Nov 29 00:35:22 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882935, encodeId=11bf88293516, content=8天还是with editor 这是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt8sqM0hUIdLXhxkWs2xSibibaHA0kP9S9FVFgNSWJlgsYpGBL2Qr66gN6C2t4eSChg9E5h88NgpnA/132, createdBy=c44d2174621, createdName=kokk1989, createdTime=Sat Sep 05 16:42:15 CST 2020, time=2020-09-05, status=1, ipAttribution=)]

2020-09-05 kokk1989

8天还是with editor 这是什么情况

98 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务